Literature DB >> 1127966

Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.

B S Bull, R A Korpman, W M Huse, B D Briggs.   

Abstract

Five heparin protocols, representative of about 30 presently used throughout the country, were analyzed. The adequacy of anticoagulation during and the precision of protamine neutralization at the conclusion of extracorporeal circulation were studied. In each of 50 patient's age, height, weight, or surface area was of no help in predicting heparin kinetics. The study group consisted of the 2 patients with the longest and the 2 patients with the shortest heparin half lives, as well as the 2 patients who showed the greatest sensitivity to heparin and the 2 who showed the least. By computer simulation, each was managed according to the five protocols and by a monitoring procedure. The protocols failed to provide safe anticoagulation or precise protamine neutralization, whereas the simplified monitoring approach was uniformly successful.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127966

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  40 in total

1.  Monitoring Anticoagulation During Percutaneous Coronary Interventions.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Safety of low dose heparin in elective coronary angioplasty.

Authors:  K T Koch; J J Piek; R J de Winter; G K David; K Mulder; J G Tijssen; K I Lie
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

3.  Intraaortic administration of protamine: Method for heparin neutralization after cardiopulmonary bypass.

Authors:  Alejandro Aris; Heriberto Solanes; Jose O. Bonnin; Rosa Garin; Jose M. Caralps
Journal:  Cardiovasc Dis       Date:  1981-03

4.  All ACTs are not created equal.

Authors:  J J Ferguson
Journal:  Tex Heart Inst J       Date:  1992

5.  An evaluation of two activated clotting time monitors during cardiac surgery.

Authors:  D L Reich; K Zahl; M H Perucho; D M Thys
Journal:  J Clin Monit       Date:  1992-01

6.  Urban myths and the ACT: what is not true and what really matters when it comes to monitoring anticoagulation.

Authors:  Bruce Searles
Journal:  J Extra Corpor Technol       Date:  2006-03

7.  Anesthesiology: doses of heparin and protamine.

Authors:  B Briggs
Journal:  West J Med       Date:  1976-10

8.  Back to the stacks--looking at classic papers related to the current practice of cardiopulmonary bypass.

Authors:  Joseph J Sistino
Journal:  J Extra Corpor Technol       Date:  2010-12

Review 9.  Heparin dose during percutaneous coronary intervention: how low dare we go?

Authors:  G Niccoli; A P Banning
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

10.  STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass.

Authors:  Linda Shore-Lesserson; Robert A Baker; Victor Ferraris; Philip E Greilich; David Fitzgerald; Philip Roman; John Hammon
Journal:  J Extra Corpor Technol       Date:  2018-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.